Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

NCT05463354 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: Recombinant COVID-19 Vaccine (Sf9 Cell)
BIOLOGICAL: COVID-19 Vaccine (Vero Cell), Inactivated

Sponsor

WestVac Biopharma Co., Ltd.